Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
38 search results for:

EULAR 2021 conference hub 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 02-06-2022 | EULAR 2022 | Conference coverage | Article
    News in brief

    Mortality risk may be ‘slightly increased’ in women with polymyalgia rheumatica

    Women with polymyalgia rheumatica may have a small increase in the risk for mortality relative to the general population, but not during the first 20 years after diagnosis, according to research presented at the EULAR 2022 Congress in Copenhagen, Denmark.

    Author:
    Claire Barnard
    Published in:
    EULAR 2022; Copenhagen, Denmark: 1–4 June Ann Rheum Dis 2022; 81 : 121
  2. 07-11-2021 | ACR 2021 | Conference coverage | Article

    High rates of severe COVID-19 in patients with vasculitis, polymyalgia rheumatica

    An analysis of data from the COVID-19 Global Rheumatology Alliance and EULAR COVID-19 registries suggests high rates of severe COVID-19 among people with primary systemic vasculitis or polymyalgia rheumatica.

    Author:
    Claire Barnard
    Published in:
    ACR Convergence 2021; 3–9 November Lancet Rheumatol 2021; doi:10.1016/S2665-9913(21)00316-7 Lancet Rheumatol 2021; doi:10.1016/S2665-9913(21)00357-X
  3. play
    02-06-2021 | EULAR 2021 | Conference coverage | Video

    COVID-19 Global Rheumatology Alliance study finds link between RA treatment and COVID-19 severity

    EULAR 2021 video: Jeffrey Sparks and Zachary Wallace talk about their findings from a COVID-19 Global Rheumatology Alliance study that shows

  4. 06-11-2021 | ACR 2021 | Conference coverage | Article

    KEEPsAKE trials show benefits of risankizumab in patients with PsA

    Treatment with the IL-23 inhibitor risankizumab may improve outcomes for patients with psoriatic arthritis, suggests an integrated analysis of data from the KEEPsAKE 1 and 2 studies presented at the ACR Convergence 2021 virtual meeting.

    Author:
    Claire Barnard
    Published in:
    ACR Convergence 2021; 3–9 November
  5. 05-06-2021 | EULAR 2021 | Conference coverage | Article

    Pfizer–BioNTech vaccine immunogenicity confirmed in patients with AIIRDs

    EULAR 2021 Virtual Congress; 2–5 June

    Author:
    Lucy Piper
    Published in:
    EULAR 2021 Virtual Congress; 2–5 June
  6. 06-06-2021 | EULAR 2021 | Conference coverage | Article
    News in brief

    ​​​​​​​Genetic study points to causal link between gout and hypertension

    A Mendelian randomization analysis presented at the EULAR 2021 Virtual Congress suggests that the association between gout and hypertension may have a causal basis.

    Author:
    Claire Barnard
    Published in:
    EULAR 2021 Virtual Congress; 2–5 June
  7. 05-06-2021 | EULAR 2021 | Conference coverage | Article
    News in brief 

    CV risk similar for gout treatments allopurinol and benzbromarone

    Allopurinol and benzbromarone have comparable cardiovascular risk profiles in patients with gout, suggests research presented in a poster at the EULAR 2021 Virtual Congress.

    Author:
    Lucy Piper
    Published in:
    EULAR 2021 Virtual Congress; 2–5 June
  8. 07-06-2021 | EULAR 2021 | Conference coverage | Article

    Upadacitinib beneficial in PsA patients with axial involvement

    There were no cases of inflammatory bowel disease among upadacitinib-treated patients. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group EULAR 2021 Virtual Congress; 2–5 June

    Author:
    Claire Barnard
    Published in:
    EULAR 2021 Virtual Congress; 2–5 June

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.